The role of baseline peripheral neutrophil to lymphocyte ratio in predicting response to neoadjuvant chemotherapy in breast cancer
Mahmoud, M., Abdelhafeez El Sayed, Z., Abdelkader, H., Ibrahim, A., Hussien, N. (2024). The role of baseline peripheral neutrophil to lymphocyte ratio in predicting response to neoadjuvant chemotherapy in breast cancer. EKB Journal Management System, 8(4), 54-60. doi: 10.21608/jcbr.2024.319101.1370
Mohamed Salah Mahmoud; Zeinab Mohamed Abdelhafeez El Sayed; Haytham Ahmed Abdelkader; Aalaa Gamil Ibrahim; Nervana M Hussien. "The role of baseline peripheral neutrophil to lymphocyte ratio in predicting response to neoadjuvant chemotherapy in breast cancer". EKB Journal Management System, 8, 4, 2024, 54-60. doi: 10.21608/jcbr.2024.319101.1370
Mahmoud, M., Abdelhafeez El Sayed, Z., Abdelkader, H., Ibrahim, A., Hussien, N. (2024). 'The role of baseline peripheral neutrophil to lymphocyte ratio in predicting response to neoadjuvant chemotherapy in breast cancer', EKB Journal Management System, 8(4), pp. 54-60. doi: 10.21608/jcbr.2024.319101.1370
Mahmoud, M., Abdelhafeez El Sayed, Z., Abdelkader, H., Ibrahim, A., Hussien, N. The role of baseline peripheral neutrophil to lymphocyte ratio in predicting response to neoadjuvant chemotherapy in breast cancer. EKB Journal Management System, 2024; 8(4): 54-60. doi: 10.21608/jcbr.2024.319101.1370

The role of baseline peripheral neutrophil to lymphocyte ratio in predicting response to neoadjuvant chemotherapy in breast cancer

Egyptian Journal of Cancer and Biomedical Research
Volume 8, Issue 4, December 2024, Page 54-60  XML PDF (658.23 K)
Document Type: Short Communication
DOI: 10.21608/jcbr.2024.319101.1370
View on SCiNiTO View on SCiNiTO
Authors
Mohamed Salah Mahmoud email 1; Zeinab Mohamed Abdelhafeez El Sayed2; Haytham Ahmed Abdelkader1; Aalaa Gamil Ibrahim1; Nervana M Hussienorcid 1
1Department of Clinical Oncology, Faculty of Medicine, Helwan University, Cairo, Egypt
2Department of Clinical Oncology, Faculty of Medicine, Ain Shams University, Cairo, Egypt
Abstract
Background: Breast cancer is a major health problem all over the world. Neutrophil-to-lymphocyte ratio (NLR) is an easy, cost-effective, readily available diagnostic tool for systemic inflammation. Aim: We aimed to evaluate whether baseline peripheral neutrophils to lymphocytes ratio in the peripheral blood of breast cancer patients are correlated with pathological complete response (pCR) following neoadjuvant. chemotherapy. Patients & Methods: This Observational prospective cohort study was carried out in the Clinical Oncology Department, Helwan University Hospitals from October 2022 to September 2023. The study involved 50 females with breast cancer who underwent treatment with neoadjuvant. chemotherapy protocol. Results: In this study, 17 patients (34%) achieved statistically significant pCR following neoadjuvant chemotherapy among the patients with lower NLR as compared to the patients with high NLR. Our study showed also that 12 (66.7%) patients in the lower NLR (<1.69) achieved pCR, while only 5 (15.6%) patients in the high NLR (≥1.69) achieved pCR (P value=0.002). Conclusion: Lower baseline peripheral NLR is associated with better rates of pCR in breast cancer patients receiving neoadjuvant chemotherapy, reflecting better treatment outcomes.
Keywords
Breast cancer; Neutrophil to lymphocyte ratio; pathological complete response
Statistics
Article View: 170
PDF Download: 103